Eculizumab as fast-acting rescue therapy for pembrolizumab-induced impending crisis state of myasthenia gravis: a case report
Immune checkpoint inhibitors, such as pembrolizumab, have demonstrated substantial therapeutic efficacy in the treatment of cancer. However, immune-related adverse events, including myasthenia gravis (MG), present significant clinical challenges. This study presents the case of a 75-year-old male pa...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publishing
2025-04-01
|
| Collection: | Therapeutic Advances in Neurological Disorders |
| Accès en ligne: | https://doi.org/10.1177/17562864251333518 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|